This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Frontiers in Cancer Immunotherapy

Available via

WEBINAR

Frontiers in Cancer Immunotherapy

Thursday, April 26, 2018 - Friday, April 27, 2018

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

Cancer Discussion Group

The New York Academy of Sciences

 

The recent FDA approval of a gene therapy for leukemia treatment marks a new frontier in medical innovation for the field of cancer immunotherapy. This 2-day scientific symposium will explore cutting-edge findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches. Plenary speakers active in the fields of cancer biology, immunology, and cancer immunotherapy will present on an array of topics, including: new mechanistic perspectives from basic and preclinical research, results from early phase clinical trials of combination therapies, the durability of treatment responses to CAR-T cell therapies, and managing the known toxicity of effective immunotherapies in clinical trials.

This symposium will feature a Career Exploration Roundtable presented in collaboration with Science Alliance. Targeting graduate students and postdoctoral fellows, this panel will feature senior postdocs and early-career scientists from industry and academia. Participants who are interested in attending this breakfast must register to attend the full Frontiers in Cancer Immunotherapy conference. Registrants will then receive a follow-up email that includes a link to register for the Career Exploration breakfast.

Registration

Member
By 03/09/2018
$175
After 03/09/2018
$200
Onsite
$250
Nonmember Academia, Faculty, etc.
By 03/09/2018
$250
After 03/09/2018
$300
Onsite
$375
Nonmember Corporate, Other
By 03/09/2018
$350
After 03/09/2018
$400
Onsite
$475
Nonmember Not for Profit
By 03/09/2018
$250
After 03/09/2018
$300
Onsite
$375
Nonmember Student, Undergrad, Grad, Fellow
By 03/09/2018
$175
After 03/09/2018
$200
Onsite
$350
Member Student, Post-Doc, Fellow
By 03/09/2018
$150
After 03/09/2018
$175
Onsite
$225
Member
$60
Nonmember Academia, Faculty, etc.
$130
Nonmember Corporate, Other
$170
Nonmember Not for Profit
$130
Nonmember Student, Undergrad, Grad, Fellow
$90
Member Student, Post-Doc, Fellow
$30
Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Deadline:
0
days
left

Organizers

Frontiers in Cancer Immunotherapy
George Zavoico, PhD, B. Riley FBR
Frontiers in Cancer Immunotherapy
Chris Boshoff, MD, PhD, Pfizer
Frontiers in Cancer Immunotherapy
Sridhar Ramaswamy, MD, Tesaro
Frontiers in Cancer Immunotherapy
Renier Brentjens, MD, PhD, Memorial Sloan Kettering Cancer Center
Frontiers in Cancer Immunotherapy
Sara Donnelly, PhD, The New York Academy of Sciences
Frontiers in Cancer Immunotherapy
Sonya Dougal, PhD, The New York Academy of Sciences

Keynote Speakers

Frontiers in Cancer Immunotherapy
Miriam Merad, MD, PhD, Icahn School of Medicine at Mount Sinai
Frontiers in Cancer Immunotherapy
Jeffrey V. Ravetch, MD, PhD, The Rockefeller University

Speakers

Frontiers in Cancer Immunotherapy
Brian Ruffell, PhD, Moffitt Cancer Center
Frontiers in Cancer Immunotherapy
Dale L. Greiner PhD, University of Massachusetts Medical School
Frontiers in Cancer Immunotherapy
Marcela V. Maus, MD PhD, Harvard Medical School​
Frontiers in Cancer Immunotherapy
Marco Davila, MD, PhD, Moffitt Cancer Center
Frontiers in Cancer Immunotherapy
Prasad S. Adusumilli, MD, Memorial Sloan Kettering Cancer Center
Frontiers in Cancer Immunotherapy
Rong Fan, PhD, Yale University
Frontiers in Cancer Immunotherapy
Hans Klingemann, MD, PhD, NantKwest
Frontiers in Cancer Immunotherapy
Timothy Chan, MD, PhD, Memorial Sloan Kettering Cancer Center
Frontiers in Cancer Immunotherapy
David Spencer, PhD, Bellicum Pharmaceuticals
Frontiers in Cancer Immunotherapy
Noah Palm, PhD, Yale University School of Medicine
Frontiers in Cancer Immunotherapy
Paolo Fiorina, MD, PhD, Harvard Medical School
Frontiers in Cancer Immunotherapy
Christopher Klebanoff, MD, Memorial Sloan Kettering Cancer Center
Frontiers in Cancer Immunotherapy
David Jenkins, PhD, Tesaro
Frontiers in Cancer Immunotherapy
Jennifer Wargo, MD, MD Anderson Cancer Center
Frontiers in Cancer Immunotherapy
Maria Fardis, PhD, MBA, Iovance Biotherapeutics
Frontiers in Cancer Immunotherapy
Rachel Humphrey, MD,CytomX Therapeutics
Frontiers in Cancer Immunotherapy
Priti Hegde, PhD, Genentech
Frontiers in Cancer Immunotherapy
Jane Gross, PhD, Aptevo Therapeutics
Frontiers in Cancer Immunotherapy
James W. Hodge, PhD, MBA, National Cancer Institute

Sponsors

The Cancer Discussion Group is Proudly Supported by:

This event is supported by medical education grants from Prometheus Laboratories, Inc and Abbvie.
 
Additional Support provided by
BioLife Solutions

Promotional Partners

American Association for Cancer Research (AACR)

Cancer Research Institute

Damon Runyon Cancer Research Foundation

Ludwig Institute for Cancer Research

Thursday

April 26, 2018

8:30 AM

Breakfast and Registration

9:00 AM

Introduction and Welcome Remarks

Speakers

Sonya Dougal, PhD
The New York Academy of Sciences
Renier Brentjens, MD, PhD
Memorial Sloan Kettering Cancer Center
9:15 AM

Combining Immune CheckPoint Blockers with Targeted Therapies

Speaker

Chris Boshoff, MD, PhD
Pfizer

Session 1: Innovative Tools for Immunotherapy

Session Chairperson
Renier Brentjens, MD, PhD, Memorial Sloan Kettering Cancer Center
9:45 AM

Current State of Humanized Mouse Models in Cancer Immunotherapy

Speaker

Dale Greiner, PhD
University of Massachusetts Medical School
10:15 AM

Single-Cell Integrative Analysis of CAR-T Cell Activation States

Speaker

Rong Fan, PhD
Yale University
10:45 AM

Insights into Modes of Action and Resistance to Checkpoint Inhibitors in Cancer

Speaker

Priti Hegde, PhD
Genentech
11:15 AM

Networking Coffee Break

Session 2: Mechanistic Perspectives driving the Next Generation of Immunotherapeutics

Session Chairperson
Dale L Greiner PhD, University of Massachusetts Medical School
11:45 AM

The Next Evolution of CD19-targeted CAR T Cells

Speaker

Marco Davila, MD, PhD
Moffitt Cancer Center
12:15 PM

CAR T-Cell Therapy for Solid Tumors

Speaker

Prasad Adusumilli, MD
Memorial Sloan Kettering Cancer Center
12:45 PM

T-Cell Therapy 2.0: Building the Next Generation of Adoptive Cancer Immunotherapies

Speaker

Christopher Klebanoff, MD
Memorial Sloan Kettering Cancer Center
1:15 PM

Networking Lunch and Poster Viewing

Session 3: Alternative Checkpoints and Cellular Therapies

Session Chairperson
Chris Boshoff, MD, PhD, Pfizer
2:30 PM

Developing Tumor Infiltrating Lymphocytes for the Treatment of Cancer

Speaker

Maria Fardis, PhD, MBA
Iovance Biotherapeutics
3:00 PM

Building on PD-1: new combinations to enhance therapeutic activity

Speaker

David Jenkins, PhD
Tesaro
3:30 PM

Networking Coffee Break

4:00 PM

Engineered, Off the Shelf, NK Cell Lines for Targeted Cancer Immunotherapy

Speaker

Hans Klingemann, MD, PhD
NantKwest
4:30 PM

TIM-3 Regulates Dendritic Cell Function and Anti-Tumor Immunity

Speaker

Brian Ruffell, PhD
Moffitt Cancer Center
5:00 PM

Keynote Lecture- Next Generation Immunotherapeutics for Cancer: Coupling Innate and Adaptive Immunity

Speaker

Jeffrey Ravetch, MD, PhD
The Rockefeller University
5:45 PM

Networking Reception and Poster Viewing

6:30 PM

Day 1 Adjourns

Friday

April 27, 2018

8:00 AM

Breakfast and Registration

8:00 AM

Early Career Development Mentoring Breakfast

Location: *Registration required. Limited to Graduate Students and Postdocs

Speakers

Michael Arensman, PhD
Pfizer
Renier Brentjens, MD, PhD
Memorial Sloan Kettering Cancer Center
Srimoyee Ghosh, PhD
Tesaro
Jeanine Pignatelli, PhD
Pfizer
Sarwish Rafiq, PhD
Memorial Sloan Kettering Cancer Center
Sridhar Ramaswamy, MD
Tesaro
9:00 AM

Welcome Remarks

Speaker

Sridhar Ramaswamy, MD
Tesaro
9:15 AM

Keynote Lecture -Tumor Immunology and Immunotherapy

Speaker

Miriam Merad, MD, PhD
Icahn School of Medicine at Mount Sinai

Session 4: Beyond Cancer Biology: Learning from Immunity

Session Chairperson
Sridhar Ramaswamy, MD, Tesaro
10:00 AM

Functional Profiling of the Gut Microbiota

Speaker

Noah Palm, PhD
Yale School of Medicine
10:30 AM

Networking Coffee Break

11:00 AM

The PD-L1/PD1 Pathways in Autoimmune Diabetes

Speaker

Paolo Fiorina, MD, PhD
Harvard Medical School
11:30 AM

Immunotherapy: What’s Genes Got to do with it?

Speaker

Timothy Chan, MD, PhD
Memorial Sloan Kettering Cancer Center

Session 5: Data Blitz Presentations (selected from poster abstract submissions)

Session Chairperson
Sridhar Ramaswamy, MD, Tesaro
12:00 PM

Lineage–tracing reveals a unique contribution of embryonic macrophages to NSCLC

Speaker

María Casanova-Acebes, PhD (Merad Laboratory)
Icahn School of Medicine at Mount Sinai
12:05 PM

CTNNB1 (Beta-Catenin) Activation Promotes Immune Escape and Resistance to Anti-PD-1 Immunotherapy in Hepatocellular Carcinoma

Speaker

Marina Ruiz De Galaretta, PhD (Lujambio Lab)
Icahn School of Medicine at Mount Sinai
12:10 PM

Networking Lunch

Session 6: Breakout Sessions

1:15 PM - 2:15 PM

Track A: Bispecific Antibody Therapeutics

Jane Gross, PhD
Aptevo Therapeutics

Track B: Vaccine as a foundation for combination immunotherapy

James Hodge, PhD, MBA
National Cancer Institute

Track C: The Microbiome in Immuno-oncology

Jennifer Wargo, MD
MD Anderson Cancer Center

Session 7: Clinical Responses and Tumor Dynamics

Session Chairperson
George Zavoico, PhD, B. Riley FBR
2:15 PM

CAR T-Cell Therapy of Cancer

Speaker

Renier Brentjens, MD, PhD
Memorial Sloan Kettering Cancer Center
2:45 PM

Switching on the Full Potency of Adoptive T-Cell Therapy Using Synthetic Biology Tools

Speaker

David Spencer, PhD
Bellicum Therapeutics
3:15 PM

Networking Coffee Break

3:45 PM

The Role of the Microbiome in Response to Cancer Therapy

Speaker

Jennifer Wargo, MD
MD Anderson Cancer Center
4:15 PM

Probody Therapeutics, Reinventing Therapeutic Antibodies for the Treatment of Cancer

Speaker

Rachel Humphrey, MD
CytomX Therapeutics
4:45 PM

CAR T-Cells in Immunotherapy

Speaker

Marcella V Maus, MD, PhD *
Harvard Medical School ( *not participating in webinar)
5:15 PM

Closing Remarks

Speaker

George Zavoico, PhD
B. Riley FBR
5:30 PM

Conference Adjourns

To view full attendee list, you must first register for the event, then log in to the Academy website. This list is provided for the personal, noncommercial and informational use only of event attendees, in a manner that is consistent with the New York Academy of Sciences’ mission, goals and activities.
  • Aaron Diamond AIDS Research Center

  • AbbVie

  • Applied BioMath, LLC

  • Apvo

  • AstraZeneca

  • B. Riley FBR

  • B.Riley FBR

  • Bellicum Pharmaceuticals

  • BioLife Solutions Inc.

  • BioScience Communications

  • Boehringer Ingelheim Pharmaceuticals

  • Bristol-Myers Squibb

  • Cancer Reports

  • Celgene Corporation

  • Chinese Academy of Sciences

  • Columbia University

  • CytomX Therapeutics, Inc.

  • DefinedHealth

  • EMD Serono

  • Forest Research Institute

  • FPRT Bio

  • Genentech

  • Harvard Medical School

  • Houston Methodist Hospital

  • Hunter College, CUNY

  • Icahn School of Medicine at Mount Sinai

  • Imclone Systems, Inc.

  • Immutep Limited

  • Iovance Biotherapeutics

  • Janssen Research & Development, LLC

  • MD Anderson

  • Memorial Sloan Kettering Cancer Center

  • Memorial Sloan-Kettering Cancer Center

  • Merck & Co., Inc.

  • Merck Research Laboratories

  • Merck Sharp & Dohme Corp.

  • Moffitt Cancer Center

  • NantKwest

  • National Cancer Institute

  • Nature Biotechnology

  • New York University Medical Center

  • Northwell Health, Inc.

  • NYU Langone Medical Center

  • Pfizer

  • Pfizer Centers for Therapeutic Innovation

  • Pfizer Global Research and Development

  • Pfizer Inc.

  • Promega

  • Prometheus Laboratories Inc.

  • Regeneron

  • Regeneron Pharmaceuticals, Inc

  • Roche Translational and Clinical Research Center (TCRC)

  • Sanofi Research & Development

  • SQI Diagnostics

  • St. John's University

  • SUNY Buffalo

  • TESARO, Inc.

  • The Albert Einstein College of Medicine

  • The City University of New York (CUNY)

  • The Damon Runyon Cancer Research Foundation

  • The Icahn School of Medicine at Mount Sinai

  • The Rockefeller University

  • The Telmarc Group

  • The Trout Group

  • Tri-Institutional Therapeutics Discovery Institute

  • University of Edinburgh

  • University of Massachusetts Medical School

  • Versant Ventures

  • Weill Cornell Medicine

  • Yale School of Medicine

  • Yale University